Search research articles
Contact Us
Filters
Showing results (1101-1110 of 1,127) with videos related to
Page
of 113
Sort By:
Blood
|
February 9, 2026
A Randomized Phase 2 Study of Ipilimumab, Nivolumab, and Brentuximab Vedotin in Patients with Relapsed Hodgkin Lymphoma
Catherine Diefenbach, Opeyemi Jegede, Victoria Wang, et al.
Blood Advances
|
December 21, 2021
Whole-transcriptome analysis in acute lymphoblastic leukemia: a report from the DFCI ALL Consortium Protocol 16-001
Thai Hoa Tran, Sylvie Langlois, Caroline Meloche, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 6, 2021
Efficacy and Toxicity of Pegaspargase and Calaspargase Pegol in Childhood Acute Lymphoblastic Leukemia: Results of DFCI 11-001
Lynda M Vrooman, Traci M Blonquist, Kristen E Stevenson, et al.
Blood Advances
|
February 11, 2026
ASH 2026 Guidelines for Management of Relapsed/Refractory Disease in Adolescents and Young Adults with ALL
Kristen M O'Dwyer, Lena E Winestone, Matthew C Cheung, et al.
Circulation
|
October 27, 2024
Fractional Flow Reserve and Instantaneous Wave-Free Ratio as Predictors of the Placebo-Controlled Response to Percutaneous Coronary Intervention in Stable Coronary Artery Disease
Michael J Foley, Christopher A Rajkumar, Fiyyaz Ahmed-Jushuf, et al.
ACS Synthetic Biology
|
March 12, 2025
Semiautomated Production of Cell-Free Biosensors
Dylan M Brown, Daniel A Phillips, David C Garcia, et al.
The Lancet. Oncology
|
November 10, 2015
Intravenous pegylated asparaginase versus intramuscular native Escherichia coli L-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial
Andrew E Place, Kristen E Stevenson, Lynda M Vrooman, et al.
Clinical Chemistry
|
June 16, 2018
Assessment of Digital PCR as a Primary Reference Measurement Procedure to Support Advances in Precision Medicine
Alexandra S Whale, Gerwyn M Jones, Jernej Pavšič, et al.
Journal of the American College of Cardiology
|
May 16, 2024
N-of-1 Trial of Angina Verification Before Percutaneous Coronary Intervention
Christopher A Rajkumar, Michael J Foley, Fiyyaz Ahmed-Jushuf, et al.
Pediatric Blood & Cancer
|
October 7, 2020
Identification of prognostic factors in childhood T-cell acute lymphoblastic leukemia: Results from DFCI ALL Consortium Protocols 05-001 and 11-001
Melissa A Burns, Andrew E Place, Kristen E Stevenson, et al.
Page
of 113
Search research articles
Search
Showing results (1101-1110 of 1,127) with videos related to
Sort By:
Page
of 113
Blood
|
February 9, 2026
A Randomized Phase 2 Study of Ipilimumab, Nivolumab, and Brentuximab Vedotin in Patients with Relapsed Hodgkin Lymphoma
Catherine Diefenbach, Opeyemi Jegede, Victoria Wang, et al.
Blood Advances
|
December 21, 2021
Whole-transcriptome analysis in acute lymphoblastic leukemia: a report from the DFCI ALL Consortium Protocol 16-001
Thai Hoa Tran, Sylvie Langlois, Caroline Meloche, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 6, 2021
Efficacy and Toxicity of Pegaspargase and Calaspargase Pegol in Childhood Acute Lymphoblastic Leukemia: Results of DFCI 11-001
Lynda M Vrooman, Traci M Blonquist, Kristen E Stevenson, et al.
Blood Advances
|
February 11, 2026
ASH 2026 Guidelines for Management of Relapsed/Refractory Disease in Adolescents and Young Adults with ALL
Kristen M O'Dwyer, Lena E Winestone, Matthew C Cheung, et al.
Circulation
|
October 27, 2024
Fractional Flow Reserve and Instantaneous Wave-Free Ratio as Predictors of the Placebo-Controlled Response to Percutaneous Coronary Intervention in Stable Coronary Artery Disease
Michael J Foley, Christopher A Rajkumar, Fiyyaz Ahmed-Jushuf, et al.
ACS Synthetic Biology
|
March 12, 2025
Semiautomated Production of Cell-Free Biosensors
Dylan M Brown, Daniel A Phillips, David C Garcia, et al.
The Lancet. Oncology
|
November 10, 2015
Intravenous pegylated asparaginase versus intramuscular native Escherichia coli L-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial
Andrew E Place, Kristen E Stevenson, Lynda M Vrooman, et al.
Clinical Chemistry
|
June 16, 2018
Assessment of Digital PCR as a Primary Reference Measurement Procedure to Support Advances in Precision Medicine
Alexandra S Whale, Gerwyn M Jones, Jernej Pavšič, et al.
Journal of the American College of Cardiology
|
May 16, 2024
N-of-1 Trial of Angina Verification Before Percutaneous Coronary Intervention
Christopher A Rajkumar, Michael J Foley, Fiyyaz Ahmed-Jushuf, et al.
Pediatric Blood & Cancer
|
October 7, 2020
Identification of prognostic factors in childhood T-cell acute lymphoblastic leukemia: Results from DFCI ALL Consortium Protocols 05-001 and 11-001
Melissa A Burns, Andrew E Place, Kristen E Stevenson, et al.
Page
of 113